Healthium Medtech, a global medical devices company focused on surgical, post-surgical and chronic care, has launched a new wound dressing portfolio Theruptor Novo for the management of chronic wounds like diabetic foot ulcers and leg ulcers

With the launch of Theruptor Novo, Healthium strengthens its existing portfolio of patented products in the advanced wound dressing segment.

India has almost 77 million patients affected with diabetes based on an NCBI survey. The lifetime risk of a person with diabetes having a foot ulcer has been reported to be as high as 25%. India witnessed almost 1 lakh registered amputations today due to complications of unmanaged diabetic foot ulcers. The treatment of foot ulcers is painful and costly.

Theruptor Novo is an anti-microbial and non-toxic wound dressing with technology patented in the US, India, EU, and Canada. This product works on a physical kill mechanism of attract, bind and rupture formula – a patented technology that minimizes the development of resistant microbes and aids in the healing process.

Speaking on the launch, Anish Bafna, CEO & MD, Healthium Medtech said, “It gives us immense pleasure to launch Theruptor Novo using our indigenous patented technology. This is another great addition to our robust and dynamic product portfolio in the wound care and infection prevention segment. We will continue to add value to our customers by manufacturing high quality precision based devices and products that address the unmet gaps and bring patient safety to the fore. We will strive towards strengthening our presence, expanding our product portfolio and delivering better patient care worldwide."

Dr. Ashok Moharana, Chief Medical Officer, Healthium Medtech said, “The launch of Theruptor Novo reinforces our commitment towards precision products for clinicians and the patient community. At Healthium we are immensely focused on innovation, safety, quality and research for holistic solutions towards the clinical and the patient community. Theruptor Novo is a patented product for the management of chronic wounds which acts through a unique physical mechanism of action, as against most of the available dressings which acts through the pharmacological mechanism. The unique 3-D Hydrocellular substrate enables wicking action facilitating adequate exudate and moisture management and provides an optimal wound healing environment.”